We are live on
!
Find out more
ONC
BeOne Medicines Ltd
93 hedge funds and large institutions have $2.69B invested in BeOne Medicines Ltd in 2017 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
109% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 11
27% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 26
15% more funds holding
Funds holding: 81 → 93 (+12)
3% more capital invested
Capital invested by funds: $2.61B → $2.69B (+$87.5M)
0.18% less ownership
Funds ownership: 4.84% → 4.66% (-0.18%)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
49% less call options, than puts
Call options by funds: $4.01M | Put options by funds: $7.86M
Holders
93
Holders Change
+12
Holders Change %
+14.81%
% of All Funds
2.11%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.18%
New
23
Increased
33
Reduced
26
Closed
11
Calls
$4.01M
Puts
$7.86M
Net Calls
-$3.85M
Net Calls Change
-$8.59M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$94.7M |
| 2 |
Temasek Holdings
Singapore
|
+$82.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22.7M |
| 4 |
Morgan Stanley
New York
|
+$17.1M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$10.6M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$24.9M |
| 2 |
MAM
Myriad Asset Management
North Point,
Hong Kong
|
-$24.6M |
| 3 |
O
OppenheimerFunds
New York
|
-$12.7M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$6.2M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.15M |
